{
    "title": "A hybrid framework with large language models for rare disease phenotyping",
    "url": "https://openalex.org/W4403174382",
    "year": 2024,
    "authors": [
        {
            "id": "https://openalex.org/A2776677562",
            "name": "Jinge Wu",
            "affiliations": [
                "UCB Pharma (United Kingdom)",
                "University College London"
            ]
        },
        {
            "id": "https://openalex.org/A1974730243",
            "name": "Hang Dong",
            "affiliations": [
                "University of Exeter"
            ]
        },
        {
            "id": "https://openalex.org/A2397416258",
            "name": "Zexi Li",
            "affiliations": [
                "University of Oxford"
            ]
        },
        {
            "id": "https://openalex.org/A2095783865",
            "name": "Haowei Wang",
            "affiliations": [
                "University College London"
            ]
        },
        {
            "id": "https://openalex.org/A4292547720",
            "name": "Runci Li",
            "affiliations": [
                "Institute for Reproductive Health",
                "University College London"
            ]
        },
        {
            "id": "https://openalex.org/A2479822347",
            "name": "Arijit Patra",
            "affiliations": [
                "UCB Pharma (United Kingdom)"
            ]
        },
        {
            "id": "https://openalex.org/A2222794254",
            "name": "Chengliang Dai",
            "affiliations": [
                "UCB Pharma (United Kingdom)"
            ]
        },
        {
            "id": "https://openalex.org/A2099430442",
            "name": "Waqar Ali",
            "affiliations": [
                "UCB Pharma (United Kingdom)"
            ]
        },
        {
            "id": "https://openalex.org/A2419194849",
            "name": "Phil Scordis",
            "affiliations": [
                "UCB Pharma (United Kingdom)"
            ]
        },
        {
            "id": "https://openalex.org/A2251773446",
            "name": "Honghan Wu",
            "affiliations": [
                "University of Glasgow",
                "University College London"
            ]
        },
        {
            "id": "https://openalex.org/A2776677562",
            "name": "Jinge Wu",
            "affiliations": []
        },
        {
            "id": "https://openalex.org/A1974730243",
            "name": "Hang Dong",
            "affiliations": []
        },
        {
            "id": "https://openalex.org/A2397416258",
            "name": "Zexi Li",
            "affiliations": []
        },
        {
            "id": "https://openalex.org/A2095783865",
            "name": "Haowei Wang",
            "affiliations": []
        },
        {
            "id": "https://openalex.org/A4292547720",
            "name": "Runci Li",
            "affiliations": []
        },
        {
            "id": "https://openalex.org/A2479822347",
            "name": "Arijit Patra",
            "affiliations": []
        },
        {
            "id": "https://openalex.org/A2222794254",
            "name": "Chengliang Dai",
            "affiliations": []
        },
        {
            "id": "https://openalex.org/A2099430442",
            "name": "Waqar Ali",
            "affiliations": []
        },
        {
            "id": "https://openalex.org/A2419194849",
            "name": "Phil Scordis",
            "affiliations": []
        },
        {
            "id": "https://openalex.org/A2251773446",
            "name": "Honghan Wu",
            "affiliations": []
        }
    ],
    "references": [
        "https://openalex.org/W3170139103",
        "https://openalex.org/W1983965561",
        "https://openalex.org/W2405275595",
        "https://openalex.org/W4283077570",
        "https://openalex.org/W4285044905",
        "https://openalex.org/W2783464703",
        "https://openalex.org/W4387609936",
        "https://openalex.org/W4323311324",
        "https://openalex.org/W2132265655",
        "https://openalex.org/W2928818852",
        "https://openalex.org/W2921415194",
        "https://openalex.org/W2778088240",
        "https://openalex.org/W4368616878",
        "https://openalex.org/W2283041611",
        "https://openalex.org/W2136410628",
        "https://openalex.org/W1994127362",
        "https://openalex.org/W2159583324",
        "https://openalex.org/W2146089916",
        "https://openalex.org/W2317648909",
        "https://openalex.org/W2765693998",
        "https://openalex.org/W2789244308",
        "https://openalex.org/W2964696298",
        "https://openalex.org/W3017637887",
        "https://openalex.org/W2911489562",
        "https://openalex.org/W4224997359",
        "https://openalex.org/W3160137267",
        "https://openalex.org/W4390607929",
        "https://openalex.org/W4385848332",
        "https://openalex.org/W4390403247",
        "https://openalex.org/W1964189668",
        "https://openalex.org/W2094791001",
        "https://openalex.org/W4313439128",
        "https://openalex.org/W4399280731",
        "https://openalex.org/W4226287018"
    ],
    "abstract": "Abstract Purpose Rare diseases pose significant challenges in diagnosis and treatment due to their low prevalence and heterogeneous clinical presentations. Unstructured clinical notes contain valuable information for identifying rare diseases, but manual curation is time-consuming and prone to subjectivity. This study aims to develop a hybrid approach combining dictionary-based natural language processing (NLP) tools with large language models (LLMs) to improve rare disease identification from unstructured clinical reports. Methods We propose a novel hybrid framework that integrates the Orphanet Rare Disease Ontology (ORDO) and the Unified Medical Language System (UMLS) to create a comprehensive rare disease vocabulary. SemEHR, a dictionary-based NLP tool, is employed to extract rare disease mentions from clinical notes. To refine the results and improve accuracy, we leverage various LLMs, including LLaMA3, Phi3-mini, and domain-specific models like OpenBioLLM and BioMistral. Different prompting strategies, such as zero-shot, few-shot, and knowledge-augmented generation, are explored to optimize the LLMsâ€™ performance. Results The proposed hybrid approach demonstrates superior performance compared to traditional NLP systems and standalone LLMs. LLaMA3 and Phi3-mini achieve the highest F1 scores in rare disease identification. Few-shot prompting with 1-3 examples yields the best results, while knowledge-augmented generation shows limited improvement. Notably, the approach uncovers a significant number of potential rare disease cases not documented in structured diagnostic records, highlighting its ability to identify previously unrecognized patients. Conclusion The hybrid approach combining dictionary-based NLP tools with LLMs shows great promise for improving rare disease identification from unstructured clinical reports. By leveraging the strengths of both techniques, the method demonstrates superior performance and the potential to uncover hidden rare disease cases. Further research is needed to address limitations related to ontology mapping and overlapping case identification, and to integrate the approach into clinical practice for early diagnosis and improved patient outcomes.",
    "full_text": null
}